Department of Radiology, Østfold Hospital Trust, Kalnes, Norway.
University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
Eur Radiol. 2022 Sep;32(9):5974-5985. doi: 10.1007/s00330-022-08711-9. Epub 2022 Apr 2.
To analyze rates, odds ratios (OR), and characteristics of screen-detected and interval cancers after concordant and discordant initial interpretations and consensus in a population-based screening program.
Data were extracted from the Cancer Registry of Norway for 487,118 women who participated in BreastScreen Norway, 2006-2017, with 2 years of follow-up. All mammograms were independently interpreted by two radiologists, using a score from 1 (negative) to 5 (high suspicion of cancer). A score of 2+ by one of the two radiologists was defined as discordant and 2+ by both radiologists as concordant positive. Consensus was performed on all discordant and concordant positive, with decisions of recall for further assessment or dismiss. OR was estimated with logistic regression with 95% confidence interval (CI), and histopathological tumor characteristics were analyzed for screen-detected and interval cancer.
Among screen-detected cancers, 23.0% (697/3024) had discordant scores, while 12.8% (117/911) of the interval cancers were dismissed at index screening. Adjusted OR was 2.4 (95% CI: 1.9-2.9) for interval cancer and 2.8 (95% CI: 2.5-3.2) for subsequent screen-detected cancer for women dismissed at consensus compared to women with concordant negative scores. We found 3.4% (4/117) of the interval cancers diagnosed after being dismissed to be DCIS, compared to 20.3% (12/59) of those with false-positive result after index screening.
Twenty-three percent of the screen-detected cancers was scored negative by one of the two radiologists. A higher odds of interval and subsequent screen-detected cancer was observed among women dismissed at consensus compared to concordant negative scores. Our findings indicate a benefit of personalized follow-up.
• In this study of 487,118 women participating in a screening program using independent double reading with consensus, 23% screen-detected cancers were detected by only one of the two radiologists. • The adjusted odds ratio for interval cancer was 2.4 (95% confidence interval: 1.9, 2.9) for cases dismissed at consensus using concordant negative interpretations as the reference. • Interval cancers diagnosed after being dismissed at consensus or after concordant negative scores had clinically less favorable prognostic tumor characteristics compared to those diagnosed after false-positive results.
在基于人群的筛查项目中,分析初始解释一致和不一致以及达成共识后,筛查发现和间隔期癌症的发生率、优势比(OR)和特征。
从挪威癌症登记处提取了 2006 年至 2017 年间参加 BreastScreen Norway 的 487118 名女性的数据,随访时间为 2 年。所有乳腺 X 线照片均由两名放射科医生独立进行解读,评分范围为 1(阴性)至 5(高度怀疑癌症)。两名放射科医生中任何一位的评分 2+定义为不一致,两名放射科医生的评分均为 2+定义为一致阳性。对所有不一致和一致阳性的情况进行了共识处理,并决定召回进行进一步评估或排除。使用具有 95%置信区间(CI)的逻辑回归估计 OR,并分析筛查发现和间隔期癌症的组织病理学肿瘤特征。
在筛查发现的癌症中,23.0%(697/3024)的评分不一致,而 12.8%(117/911)的间隔期癌症在指数筛查时被排除。与具有一致阴性评分的女性相比,在共识中被排除的女性,间隔期癌症的调整 OR 为 2.4(95%CI:1.9-2.9),随后筛查发现的癌症为 2.8(95%CI:2.5-3.2)。我们发现,与指数筛查后的假阳性结果相比,在被排除后被诊断为 DCIS 的间隔期癌症为 3.4%(4/117),而 20.3%(12/59)。
在这项针对 487118 名参加独立双读和共识筛查项目的女性的研究中,两名放射科医生中只有一名对 23%的筛查发现的癌症进行了阴性评分。与具有一致阴性评分的女性相比,在共识中被排除的女性发生间隔期和随后筛查发现的癌症的几率更高。我们的研究结果表明,个性化随访是有益的。
在这项针对使用独立双读和共识的筛查项目中 487118 名女性的研究中,只有一名放射科医生检测到 23%的筛查发现的癌症。
对于使用一致阴性解释作为参考的被排除在共识之外的病例,间隔期癌症的调整优势比为 2.4(95%置信区间:1.9,2.9)。
与指数筛查后假阳性结果相比,在共识中被排除或具有一致阴性评分后被诊断为 DCIS 的间隔期癌症的临床预后肿瘤特征较差。